Short Analytical ReviewAutoimmunity during lymphopenia: A two-hit model
Introduction
The ongoing development of T-cell-based immunotherapy for cancer has focused primarily on vaccines to boost the immune system's ability to recognize tumors as foreign and on adoptive cellular therapy to provide large numbers of tumor-specific effectors. Significant progress has been made in both arenas and promising early clinical results have been reported, but immunotherapy for cancer has not yet had a major impact on this devastating disease [1]. A major issue that continues to limit the effectiveness of T-cell-based immunotherapy for cancer is the difficulty in overcoming tolerance to self-tissues, which tumors represent. To address this, tumor immunotherapists have recently turned to studies of lymphopenia and autoimmunity to identify clues regarding the critical factors necessary to break self-tolerance.
Mechanistic studies, animal models, and clinical experience have demonstrated that alterations in T cell homeostasis induced by lymphopenia are permissive for the breaking of self-tolerance. At the same time, because most lymphopenic hosts do not develop autoimmune disease, important cofactors must also be required to break self-tolerance, even in the setting of lymphopenia. Clues to the nature of the cofactors required for lymphopenia-associated autoimmunity can be gleaned from murine models and clinical studies wherein autoimmune diseases occur in lymphopenic hosts. In this report, we will briefly review the basic biology of lymphopenia as it relates to self-tolerance, then discuss in detail the murine and human settings wherein autoimmune disease occurs in the context of lymphopenia. Our goal is to identify critical common elements among lymphopenia/autoimmunity syndromes, which could guide the development of testable hypotheses for inducing cancer-specific autoimmunity in lymphopenic humans.
Section snippets
T cell homeostasis, lymphopenia, and homeostatic peripheral expansion
Peripheral T cell expansion plays a central role in both T cell maintenance and regeneration. Primary T cell development occurs largely via thymopoiesis but efficient seeding of the neonatal peripheral T cell pool requires post-thymic expansion [2]. Further, because thymic involution occurs early in life, maintenance of the peripheral T cell pool occurs primarily via thymic-independent pathways, and when T cell depletion occurs postnatally, thymic regenerative capacity is limited [3]. Recent
Implications, applications, and conclusions
Together, the mouse and human data demonstrate that although there is a substantial interface between lymphopenia and autoimmunity, the two entities can exist independently from one another. Further, when autoimmunity is associated with lymphopenia, the T cell depletion plays a predisposing role, but it is insufficient to fully explain the loss of self-tolerance. Instead, multiple cofactors appear capable of inducing a loss of self-tolerance during lymphopenia (Fig. 1). We hypothesize that
Acknowledgments
The authors are supported by the Intramural Research Program of the U.S. National Institutes of Health, National Cancer Institute, Center for Cancer Research. Tom Krupica Jr. is also supported by the HHMI-NIH Research Scholars Program.
References (61)
Neonates support lymphopenia-induced proliferation
Immunity
(2003)T cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny
Blood
(1993)- et al.
Designing and maintaining the mature TCR repertoire: the continuum of self-peptide:self-MHC complex recognition
Immunity
(1999) The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery
Immunity
(1999)Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity
Blood
(2000)Homeostatic expansion of T cells during immune insufficiency generates autoimmunity
Cell
(2004)Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors
Immunity
(2004)- et al.
Immune reconstitution syndromes in human immunodeficiency virus infection following effective antiretroviral therapy
Immunobiology
(2000) - et al.
Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals
Lancet Infect. Dis.
(2005) - et al.
Systemic inflammatory reaction after starting highly active antiretroviral therapy in AIDS patients treated for extrapulmonary tuberculosis
Am. J. Med.
(1999)
Long-term posterior and anterior segment complications of immune recovery uveitis associated with cytomegalovirus retinitis
Am. J. Ophthalmol.
Immune recovery uveitis
Am. J. Ophthalmol.
Adverse events of desirable gain in immunocompetence: the immune restoration inflammatory syndromes
Autoimmun. Rev.
Sustaining the graft-versus-tumor effect through posttransplant immunization with granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing tumor vaccines
Blood
Mechanisms of focal heat destruction of liver tumors
J. Surg. Res.
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
Nat. Med.
Thymic aging and T-cell regeneration
Immunol. Rev.
Age-dependent incidence, time course, and consequences of thymic renewal in adults
J. Clin. Invest.
Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy
N. Engl. J. Med.
T cell repopulation from functionally restricted splenic progenitors: 10,000-fold expansion documented by using limiting dilution analyses
J. Immunol.
The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance
J. Immunol.
Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing
J. Immunol.
Recent immune status determines the source of antigens that drive homeostatic T cell expansion
J. Immunol.
Postthymic T cell development
Immunological Reviews
Organ-specific autoimmunity induced by lymphopenia
Immunol. Rev.
Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice
Int. Immunol.
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases
J. Immunol.
Cutting edge: depletion of CD4+ CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease
J. Immunol.
An autoimmune disease with multiple molecular targets abrogated by the transgenic expression of a single autoantigen in the thymus
J. Exp. Med.
Genetic susceptibility to post-thymectomy autoimmune diseases in mice
Immunogenetics
Cited by (157)
Impact and associations of lymphopenia in a cohort of Egyptian systemic lupus erythematosus patients: Potential link to complement (C3) and corticosteroids
2021, Egyptian RheumatologistCitation Excerpt :Lymphopenia in SLE is independently associated with neurologic involvement and organ damage accrual, and thus, may be considered as a marker of severe/progressive disease [9]. Kuprika et al [10] postulated that lymphopenia causes temporal dysfunction of the mechanisms typically involved in the host’s immune tolerance. This causes proliferation of peripheral T cells, which, with a second ‘hit’ (i.e. inflammation), could stimulate the development of autoimmune pathology.
Idiopathic CD4 lymphocytopenia in neurological disorders
2020, Clinical Neurology and NeurosurgeryCitation Excerpt :postulated that lymphopenia leads to vigorous cycling of self-reactive T-cells, which are prone to immune dys-homeostasis, with loss of self-tolerance. This, in association with a ‘second hit’, such as cytokine overproduction, local tissue inflammation or an infection, leads to auto-immunity against various tissues, including the nervous system, resulting in immune mediated neuropathy, myopathy, neuro-muscular dysfunction or CNS damage and demyelination [2]. This view is supported by the occurrence of autoimmune thyroiditis [3], immune radiculoneuropathies [3,4], multiple sclerosis and myasthenia gravis [5] in patients with ICL.
Specific Patterns of Immune Cell Dynamics May Explain the Early Onset and Prolonged Efficacy of Cladribine Tablets: A MAGNIFY-MS Substudy
2023, Neurology: Neuroimmunology and NeuroInflammationInflammatory Cytokines That Enhance Antigen Responsiveness of Naïve CD8<sup>+</sup> T Lymphocytes Modulate Chromatin Accessibility of Genes Impacted by Antigen Stimulation
2022, International Journal of Molecular Sciences